Ultrasound Genomics Reveals a Signature for Predicting Breast Cancer Prognosis and Therapy Response

Breast cancer (BC) in women is the most common malignancy worldwide, but there is still a lack of validated tools to accurately assess patient prognosis and response to available chemotherapy treatment regimens.